bat
order
chiroptera
abund
group
mammal
tremend
ecolog
valu
insectivor
plant
dispers
role
reservoir
zoonot
diseas
receiv
attent
last
decad
goal
manag
diseas
freerang
bat
test
modifi
vaccinia
ankara
mva
raccoon
poxviru
rcn
potenti
vaccin
vector
brazilian
freetail
bat
tadarida
brasiliensi
use
biophoton
vivo
imag
immunogen
studi
anim
administ
recombin
poxvir
vector
express
luciferas
gene
mvaluc
rcnluc
oronas
intramuscular
im
rout
subsequ
monitor
bioluminesc
signal
indic
viral
infect
clinic
ill
note
exposur
vector
limit
luciferas
express
observ
higher
longer
level
express
observ
rcnluc
construct
given
im
luciferas
express
limit
site
inject
exposur
led
initi
express
oral
caviti
often
follow
secondari
replic
anoth
locat
like
gastric
mucosa
gastric
associ
lymphat
tissu
viral
dna
detect
oral
swab
day
post
infect
dpi
mva
rcn
respect
live
viru
detect
oral
swab
mvainfect
bat
titer
x
pfuml
recov
oral
swab
rcninfect
bat
viral
dna
also
detect
fecal
sampl
two
bat
inocul
im
rcn
live
viru
recov
final
examin
immunogen
rcn
base
rabi
vaccin
rcng
follow
administr
signific
rabi
neutral
antibodi
titer
detect
serum
immun
bat
use
rapid
fluoresc
focu
inhibit
test
rffit
studi
highlight
safeti
immunogen
attenu
poxvirus
potenti
use
vaccin
vector
bat
publish
elsevi
ltd
infect
attenu
poxviru
vaccin
vector
immunogen
raccoonpox
vector
rabi
vaccin
brazilian
freetail
bat
tadarida
brasiliensi
last
decad
import
bat
order
chiroptera
mainten
transmiss
zoonot
diseas
becom
increasingli
evid
bat
thought
harbor
zoonot
agent
per
speci
list
pathogen
infect
bat
includ
major
mammalian
paramyxovirus
coronavirus
filovirus
distinct
influenza
lineag
hepadnavirus
hantavirus
well
lyssavirus
rabi
viru
unit
state
bat
often
common
sourc
rabi
infect
human
central
south
america
rabi
transmit
vampir
bat
seriou
zoonot
econom
issu
associ
bat
pathogen
significantli
impact
human
popul
increas
public
fear
misunderstand
anim
lead
cull
campaign
unfortun
cull
campaign
often
lead
death
valuabl
nontarget
bat
speci
appear
ineffect
reduc
diseas
incid
altern
vaccin
wildlif
http
speci
success
mitig
public
health
impact
rabi
develop
effici
practic
distribut
method
mass
immun
poxvir
vector
use
extens
oral
vaccin
control
infecti
diseas
varieti
anim
speci
last
year
sever
advantag
poxvirus
vaccin
vector
includ
allow
larg
insert
foreign
dna
eas
manufactur
thermal
genet
stabil
safeti
infect
multipl
target
speci
abil
infect
via
mucos
dermal
rout
exampl
oral
rabi
vaccin
construct
insert
rabi
g
glycoprotein
vaccinia
viru
distribut
via
bait
use
mani
year
curtail
rabi
outbreak
fox
raccoon
anim
north
america
europ
previou
studi
assess
vacciniabas
rabi
vaccin
vrg
desmodu
bat
demonstr
protect
efficaci
construct
howev
vector
undesir
sideeffect
especi
immunocompromis
individu
necessit
develop
attenu
viru
strain
recent
oral
sylvat
plagu
vaccin
use
anoth
poxviru
raccoon
pox
rcn
shown
protect
prairi
dog
current
test
largescal
field
trial
rcn
first
isol
upper
respiratori
tract
appar
healthi
raccoon
north
america
sinc
shown
safe
effect
varieti
speci
includ
domest
cat
piglet
dog
raccoon
skunk
fox
bobcat
rabbit
sheep
prairi
dog
nonhuman
primat
chicken
none
immun
anim
show
clinic
side
effect
addit
rcn
shown
immunogen
via
nonparenter
rout
domest
speci
free
rang
wildlif
anoth
orthopoxviru
vector
modifi
vaccinia
ankara
mva
highli
attenu
form
vaccinia
also
demonstr
safe
effect
induc
immun
base
success
mucos
vaccin
poxviru
vector
mani
speci
hypothes
poxvirus
could
immunogen
safe
given
mucos
chiropteran
speci
test
assess
infect
pathogen
mva
rcn
brasiliensi
via
vivo
imag
studi
immunogen
rcn
given
oronas
also
assess
use
standard
serolog
techniqu
vaccin
rcnbase
rabi
vaccin
rcng
use
bat
experi
approv
protocol
conduct
accord
us
geolog
survey
usg
nation
wildlif
health
center
nwhc
anim
care
use
committe
acuc
adult
male
bat
brasiliensi
n
caught
brazo
counti
texa
texa
park
wildlif
depart
permit
number
texa
univers
acuc
approv
number
courtesi
mike
smotherman
texa
univers
usa
acclim
captiv
bat
transfer
nwhc
madison
wisconsin
usa
bat
studi
conduct
condit
upon
transfer
nwhc
bat
maintain
flight
cage
quarantin
period
day
time
blood
sampl
taken
bat
treat
topic
parasit
electron
microchip
identif
unit
avid
identif
system
inc
folsom
louisiana
usa
insert
anim
scapula
via
subcutan
inject
bat
maintain
mealworm
tenebrio
molitor
supplement
vitamin
omega
fatti
acid
mixtur
water
avail
ad
libitum
light
cycl
set
h
light
per
day
invert
natur
cycl
allow
monitor
bat
activ
facil
work
hour
rcnluc
strain
use
studi
previous
describ
mvagfp
strain
use
creat
mvaluc
construct
gener
provid
inviragen
madison
wi
rcng
kindli
provid
center
diseas
control
atlanta
ga
recombin
virus
gener
amplifi
cell
monolay
rat
embryon
fibroblast
atcc
babi
hamster
kidney
cell
atcc
african
green
monkey
kidney
epitheli
cell
vero
atcc
primari
chicken
embryo
fibroblast
cef
charl
river
laboratori
inc
wilmington
wa
usa
cell
cultur
maintain
co
dulbecco
modifi
eagl
medium
dmem
optimem
life
technolog
madison
wi
supplement
fetal
bovin
serum
fb
virus
titrat
prior
use
plaqu
dilut
assay
plate
recombin
mvaluc
virus
construct
describ
elsewher
briefli
cef
cell
infect
mvagfp
multipl
pfu
per
cell
one
hour
later
cell
transfect
use
fugen
reagent
protocol
promega
fitchburg
wi
transfer
plasmid
contain
dna
flank
segment
adjac
delet
iii
within
hindiii
fragment
mva
red
fluoresc
protein
rfp
control
promot
firefli
luciferas
gene
luc
control
strong
synthet
earlyl
sel
vaccinia
viru
promot
upstream
fig
h
post
transfect
cell
cultur
put
three
freezethaw
cycl
harvest
sonic
centrifug
min
sonic
cell
extract
plate
onto
fresh
cell
overlaid
agaros
h
use
specif
microscop
filter
recombin
virus
detect
presenc
rfp
gene
replac
gfp
gene
homolog
recombin
select
cellviru
sampl
sonic
plate
describ
four
consecut
round
plaqu
isol
recombin
mvaluc
viru
confirm
pcr
analysi
use
onetaq
quickload
master
mix
standard
buffer
new
england
biolab
inc
ipswich
usa
amplifi
insert
del
iii
flank
use
atgcggcacctctcttaa
forward
primer
ccaaagcttgcacatacataagta
revers
primer
viru
subsequ
amplifi
freshli
prepar
cef
cell
biophoton
luminesc
imag
bli
success
use
assess
infect
infect
cours
tissu
tropism
virus
candid
vaccin
vector
unlik
tradit
pathogen
studi
requir
euthanasia
anim
differ
time
point
bli
allow
studi
cours
infect
time
singl
host
increas
inform
gain
reduc
number
anim
requir
group
wildcaught
brasiliensi
separ
two
screen
flight
cage
w
h
approxim
apart
four
bat
group
given
plaqu
form
unit
pfu
either
rcnluc
mvaluc
intramuscular
im
inject
split
two
volum
inject
thigh
muscl
remain
four
bat
group
given
amount
viru
steril
salin
use
micropipett
steril
tip
volum
split
among
nostril
given
nare
mouth
oronas
exposur
bat
monitor
h
post
inocul
sign
advers
effect
anim
scan
use
ivi
biophoton
imag
perkinelm
hopkinton
usa
oneday
post
infect
dpi
everyoth
day
thereaft
consecut
imag
less
radianc
unit
compar
background
observ
bat
scan
prior
infect
confirm
autoluminesc
beyond
background
level
imag
conduct
roughli
time
period
day
midway
bat
activ
period
imag
day
bat
separ
individu
paper
lunch
bag
weigh
inject
intraperiton
ip
dluciferin
potassiumluciferin
gold
biotechnolog
st
loui
mo
dose
mgkg
min
prior
imag
group
min
prior
imag
im
group
empir
determin
time
peak
luminesc
post
substrat
exposur
first
day
imag
bat
examin
sign
diseas
discomfort
time
substrat
inject
imag
anim
anesthet
chamberdeliv
isofluran
posit
imag
dorsal
recumb
wing
extend
later
maintain
maskdeliv
isofluran
imag
anesthesia
ceas
bat
monitor
given
thermal
support
recoveri
dpi
bat
remain
detect
luminesc
imag
everi
day
luminesc
detect
level
imag
collect
analyz
use
live
imag
softwar
calip
life
scienc
alameda
california
usa
region
interest
roi
creat
cover
entir
bodi
bat
analyz
luminesc
data
dpi
random
group
six
bat
initi
expos
rcnluc
either
n
im
n
rout
given
booster
exposur
rcnluc
vaccin
via
rout
dose
bat
group
imag
dpi
use
protocol
describ
anesthesia
imag
timepoint
oral
swab
collect
classiqswab
copan
flock
technolog
brescia
itali
place
ml
tube
contain
dmem
media
fecal
sampl
also
retriev
avail
bag
individu
contain
imag
place
ml
tube
without
media
sampl
quickli
mvaluc
sampl
posit
well
assess
viral
titer
luciferas
marker
use
steadylit
plu
tm
perkinelm
inc
waltham
serial
dilut
made
use
infect
well
plate
cell
confluenc
due
minim
sampl
volum
left
smaller
dilut
possibl
day
infect
steadylit
reagent
ad
well
mix
pipet
min
plate
scan
luminomet
verita
tm
micropl
luminomet
turner
biosystem
inc
sunnyval
ca
addit
group
five
brasiliensi
hous
separ
type
cage
given
rcng
via
rout
assess
immunogen
rcndeliv
rabi
cv
strain
glycoprotein
exposur
bat
anesthet
isofluran
prior
exposur
dose
pfu
viral
vaccin
given
steril
salin
split
oral
nare
bat
monitor
anesthesia
recoveri
h
potenti
advers
event
serum
sampl
obtain
prior
vaccin
dpi
test
presenc
antirabi
neutral
antibodi
rapid
fluoresc
focu
inhibit
test
rffit
serum
sampl
bat
given
rcnluc
use
luminesc
studi
also
collect
dpi
use
control
serum
collect
make
small
lanc
interfemor
vein
collect
blood
capillari
tube
microvett
cb
blood
collect
system
sarstedt
ag
co
germani
subsequ
centrifug
min
micropipett
use
collect
serum
top
blood
contain
transfer
separ
tube
storag
test
conduct
cdc
poxviru
rabi
branch
use
standard
rffit
protocol
augment
smaller
volum
serum
previous
describ
assay
run
triplic
sampl
result
report
repres
averag
titer
prior
dpi
sampl
collect
two
bat
rcng
group
lost
studi
due
nonvaccin
relat
mortal
analysi
data
perform
use
rcommand
softwar
packag
weight
chang
analyz
repeat
measur
anova
weight
function
group
rout
time
plu
interact
use
individu
bat
repeat
measur
differ
luminesc
analyz
use
linear
mixedeffect
model
fit
restrict
maximum
likelihood
approach
reml
assess
infect
tissu
tropism
cours
infect
rcn
mva
brasiliensi
bat
infect
recombin
viru
express
firefli
luciferas
gene
luc
two
rout
assess
im
rout
rout
biolog
relev
wildlif
vaccin
throughout
studi
clinic
sign
diseas
lesion
signific
weight
loss
observ
administr
viral
vector
fig
tabl
bat
infect
lucexpress
poxviru
vector
detect
express
luminesc
dpi
peak
level
observ
dpi
im
rout
respect
fig
viral
infect
via
im
exposur
clear
within
day
mva
day
rcn
infect
exposur
clear
within
day
mva
day
rcn
final
imag
rcn
given
shown
statist
analysi
reveal
luminesc
significantli
higher
p
bat
receiv
rcn
compar
mva
significantli
higher
p
administ
viru
im
rout
compar
rout
im
inject
group
signific
viral
spread
area
evid
contrast
initi
site
viral
replic
evid
oral
caviti
exposur
often
follow
secondari
site
express
gastrointestin
tract
luminesc
measur
list
tabl
group
bat
reexpos
rcnluc
assess
whether
prior
exposur
would
affect
infect
viral
vector
signific
differ
p
detect
luminesc
compar
initi
exposur
dpi
fig
pcr
analysi
oral
swab
reveal
presenc
mvaluc
dna
bat
dpi
infect
im
infect
howev
live
viru
recov
rcnluc
dna
present
bat
dpi
infect
im
infect
low
level
live
viru
detect
pfuml
averag
median
pfuml
detect
viru
two
bat
rcnluc
group
live
viru
detect
oral
swab
also
pcr
posit
fecal
sampl
dpi
howev
live
viru
recover
sampl
titrat
viral
shed
appear
occur
low
level
independ
rout
exposur
evid
shed
viabl
mva
assess
immunogen
rcn
addit
group
bat
n
infect
via
rout
rcn
express
rabi
viru
surfac
glycoprotein
rcng
evid
clinic
diseas
vaccin
bat
experi
rabi
viru
g
well
character
known
induc
protect
humor
immun
rabi
viru
bat
assess
rffit
neglig
ab
titer
prior
vaccin
tabl
control
bat
vaccin
lucexpress
viru
imag
studi
n
bled
dpi
assess
rffit
well
dpi
rabi
vaccin
bat
develop
ab
titer
greater
iuml
mean
bat
receiv
rcnluc
titer
iuml
tabl
protect
level
rabi
viru
neutral
antibodi
rvna
posit
correl
rvna
titer
level
protect
viru
challeng
titer
iu
protect
mammalian
speci
despit
associ
bat
zoonot
diseas
current
signific
effort
decreas
incid
import
infecti
diseas
anim
instead
effort
focus
cull
popul
eg
vampir
bat
latin
america
control
diseas
spillov
anim
host
continu
spillov
rabi
viru
strain
human
domest
anim
terrestri
carnivor
led
develop
success
oral
rabi
vaccin
orv
program
europ
north
america
campaign
often
util
recombin
viral
vector
stimul
immun
surfac
glycoprotein
rabi
ingest
oral
distribut
bait
target
toward
certain
rabiescarri
speci
vaccin
lead
protect
viru
reduct
local
incid
diseas
even
local
erad
strain
rabi
orv
program
continu
evolv
make
use
best
avail
vaccin
technolog
diseas
model
studi
studi
assess
whether
two
attenu
poxvirus
might
viabl
vaccin
vector
bat
speci
vivo
imag
studi
demonstr
attenu
mva
rcn
abl
infect
brasiliensi
via
rout
limit
time
without
caus
diseas
studi
demonstr
tissu
tropism
cours
infect
exposur
new
anim
model
brasiliensi
attenu
orthopoxvirus
show
evid
limit
autolog
spread
virus
exposur
although
evid
viru
spread
outsid
giassoci
tissu
mva
clear
faster
result
less
detect
luminesc
compar
rcn
may
expect
due
highli
attenu
natur
mva
lack
signific
differ
level
viral
encod
protein
luciferas
product
upon
reinfect
rcn
shown
booster
studi
fig
may
import
bat
previous
expos
rcn
boost
inocul
rcnvector
vaccin
necessari
neither
vector
caus
clinic
ill
fact
rcn
produc
viral
encod
protein
luciferas
longer
period
suggest
immunogen
vector
express
heterolog
antigen
due
limit
studi
abl
compar
immunogen
vector
directli
develop
signific
level
rabi
neutral
antibodi
exposur
rcng
demonstr
vaccin
highli
immunogen
brasiliensi
previou
studi
demonstr
effect
inject
vaccin
speci
studi
first
demonstr
effect
mucos
vaccin
averag
antirabi
g
titer
iu
dpi
detect
bat
oral
administ
rcng
higher
level
obtain
vaccin
vrg
construct
previou
studi
includ
oral
im
scarif
rout
exposur
differ
may
due
anim
model
use
addit
evid
superior
rcn
vector
vaccinia
bat
speci
addit
previou
studi
fail
address
infect
vaccinia
bat
host
reli
lack
clinic
diseas
develop
protect
immun
assess
virushost
interact
unabl
assess
durat
immun
past
day
would
use
inform
collect
futur
studi
limit
oral
shed
rcn
viru
detect
bat
pcr
cultur
live
viru
dpi
low
level
evid
shed
live
mva
viru
pcr
evid
vector
dna
oral
swab
dpi
detect
live
viru
may
limit
due
method
use
necessari
lack
lower
dilut
result
low
sampl
volum
one
advantag
vivo
imag
studi
necessari
sacrific
anim
obtain
data
bat
use
studi
went
use
differ
investig
unabl
assess
organ
tissu
evid
patholog
infect
trial
howev
lack
appar
morbid
rcntreat
bat
along
rcn
averag
luciferas
express
per
vector
rout
time
four
group
bat
given
luciferaseexpress
construct
luminesc
given
photonssecondcm
steridian
pscm
sr
luminesc
significantli
higher
p
receiv
raccoon
poxviru
rcn
modifi
vaccinia
ankara
mva
also
higher
p
administ
viru
intramuscular
im
rout
compar
oronas
rout
fig
averag
luciferas
express
oronas
exposur
raccoon
poxviru
rcn
initi
reexposur
luminesc
given
photon
secondcm
steridian
pscm
sr
signific
differ
p
detect
luminesc
compar
initi
exposur
day
post
infect
natur
histori
record
success
variou
domest
nondomest
speci
abil
induc
immun
via
oral
rout
make
attract
candid
use
freerang
bat
result
experi
provid
proofofprincipl
oral
vaccin
possibl
freerang
bat
futur
work
topic
vehicl
develop
could
use
deliv
oral
vaccin
fur
coat
bat
roost
otherwis
congreg
bat
fastidi
anim
spend
larg
proport
time
selfgroom
could
lead
signific
oral
exposur
topic
appli
vaccin
vaccin
would
broadli
protect
freerang
bat
rabi
viru
infect
may
reduc
local
incid
rabi
certain
bat
popul
limit
amount
spillov
human
speci
brasiliensi
repres
speci
roost
dens
coloni
expos
signific
level
circul
rabi
viru
popul
may
result
human
exposur
therefor
topic
deliv
rabi
vaccin
may
directli
applic
speci
method
mass
applic
spray
could
develop
research
requir
assess
viral
vector
speci
vampir
bat
desmodu
spp
topic
distribut
poison
protocol
well
develop
cull
coloni
cull
success
reduc
overal
number
desmodu
local
level
reduc
incid
rabi
bat
popul
may
inde
counterproduct
develop
topic
poxviru
vector
vaccin
could
potenti
lead
effect
applic
practic
mean
reduc
diseas
burden
free
rang
bat
popul
